Ovasave Empowers Women To Tackle Difficult Fertility Choices

Abu Dhabi-based Ovasave is on a mission to empower women to take control of their fertility. Founded by Torkia Mahloul and Majd Abu Zant, the startup seeks to ease the complexity of freezing eggs while encouraging women to start testing their ovarian reserves at thirty years of age to improve their chances of becoming pregnant in the future.

Ovasave’s digitized process is centered around a $100 FDA-approved self-administered home hormone test, followed by a remote consultation by a doctor from a vetted fertility clinic network. Depending on the results and the consultation outcome, patients can opt for an egg-freezing package from one of the clinics in the network.

“Access to fertility services is a major issue. Women are delaying having children, so their fertility is declining, but they are not acting on it because of a lack of awareness […] and because the fertility journey is fragmented and complex,” Ms Mahloul says.

Recent changes to reproductive health laws in the United Arab Emirates now allow single and married women to preserve eggs for both social and medical reasons (including pursuing education or career advancement or undergoing cancer treatments).

According to co-founder Abu Zant, freezing eggs costs around Dh25,000 per cycle, with storage averaging another Dh1,500 per year. In the UAE, frozen eggs can be legally stored for five years, with an option to extend by an additional five years.

Also Read: LVL Wellbeing Receives $10 Million Investment To Scale Operations

Ovasave is partnering with eight UAE fertility clinics and twenty IVF specialists. Users will be able to rate doctors so that other women can compare the reviews when they book a consultation.

So far, the co-founders have invested $400,000 into the startup and are seeking to raise up to $2 million over the coming six months. The funds will be used for technical development, recruitment, and general market growth.